20-F - Kamada Ltd | Modeledge

Filing type: 20-F
Filing date: Mar 14, 2023
Updated: Mar 15, 2023 · 1:14 AM

Filing

20-FAnnual and Transition Report of Foreign Private Issuers

Exhibits

EX-4.23COMPENSATION POLICY FOR EXECUTIVE OFFICERS EX-4.24COMPENSATION POLICY FOR DIRECTORS EX-4.25KAMADA LTD. 2011 ISRAELI SHARE AWARD PLAN EX-4.37AMENDED AND RESTATED MANUFACTURING SERVICES AGREEMENT DATED AS OF SEPTEMBER 28, 2017, BY AND BETWEEN EMERGENT BIOSOLUTIONS, INC. AND APTEVO THERAPEUTICS INC. (ASSUMED BY KAMADA LTD.)EX-4.38CONTRACT MANUFACTURING, SERVICES AND SUPPLY AGREEMENT DATED NOVEMBER 29, 2022, BY AND BETWEEN KAMADA LTD. AND PROTHYA BIOSOLUTIONS BELGIUM EX-4.39SUPPLEMENTAL LETTER AGREEMENT DATED AS OF JULY 4, 2022, BY AND BETWEEN KAMADA LTD. AND TUTEUR S.A.C.I.F.I.A.EX-4.402ND AMENDMENT TO THE DISTRIBUTION AGREEMENT, DATED AS OF FEBRUARY 22, 2023, BY AND BETWEEN KAMADA LTD. AND TUTEUR S.A.C.I.F.I.A.EX-8.1SUBSIDIARIES OF THE REGISTRANT EX-12.1CERTIFICATION EX-12.2CERTIFICATION EX-13.1CERTIFICATION EX-15.1CONSENT OF ERNST & YOUNG GLOBAL, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM GRAPHICGraphic